Guardant Health, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GH | NTRA | PSNL | BLLN | CSTL | NEO | |
|---|---|---|---|---|---|---|
| Market cap | 21.85B | 57.34B | 1.69B | 4.39B | 1.00B | 2.08B |
| P/E (TTM) | — | — | — | 147.7 | — | — |
| Forward P/E | -394.5 | -2,014.0 | -16.8 | 62.7 | -34.9 | 47.8 |
| Price/book | -97.6 | 31.4 | 7.1 | 8.1 | 2.1 | 2.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +171.29% | +130.07% | +94.41% | −9.96% | +50.90% | +75.05% |
| Today | −2.79% | −0.73% | −1.25% | −5.12% | −4.82% | −0.92% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All GH news ›Guardant Health Test Nabs CE Mark for use With Etcamah
Guardant Health Assay Nabs CE Mark as CDx for AstraZeneca’s Etcamah in Breast Cancer Genome Web Guardant Health Assay Nabs CE Mark as CDx for AstraZenecaâs Etcamah in Breast Cancer
Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer
BioSpace Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer - Guardant360 CDx can now help identify cancer mutations…
Guardant Health gains European CE mark for ESR1 breast cancer test
Guardant360 CDx can identify ESR1 mutations before progression in eligible advanced breast cancer; Guardant's Oct. 8 release gave no European payer terms. A European companion diagnostic label now covers blood testing for ESR1 mutations in…
Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy?
Guardant has seven times the revenue, a better gross margin and an operating loss one eighth the size. It funded that with $1.70 billion of debt against negative book value of $1.67 a share, while Grail holds $861.61 million of cash…
Guardant Health Announces Approval In Europe Of Guardant360® Cdx
TradingView Guardant Health Announces Approval In Europe Of Guardant360® Cdx
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
TRexBio Announces Pricing of Initial Public Offering Guardant Health (GH) will report its third-quarter 2026 financial results after market close on Thursday, November 5, 2026. PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc.…
Guardant Health Inc Stock (GH) Moved Down by 8.27% on Oct 6: What Investors Need To Know
TradingKey Guardant Health Inc Stock (GH) Moved Down by 8.27% on Oct 6: What Investors Need To Know What is driving Guardant Health Inc (GH)’s stock price down today? The sharp downward movement in Guardant Health shares reflects…
Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma
BioSpace Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma - First published prospective, multicenter study of Guardant…
Guardant Health (GH) Price Forecast: Breakout Opens Path Toward $250
Nasdaq Index: Record High Tests Rally as Treasury Yields and Dow Diverge Together, these patterns show a long-term upside breakout accompanied by bullish signals from two shorter-term consolidation patterns. The longer and shorter…
Nasdaq Breaks Out To New Highs; Shopify, Taiwan Semiconductor, Guardant Health In Focus - Video - IBD
Oct 5, 2026|04:39 PM ET|RACHEL FOX, ALISSA CORAM Alissa Coram and Rachel Fox walk through Monday's market action and discuss key stocks to watch in Stock Market Today. Nasdaq Breaks Out To New Highs; Shopify, Taiwan Semiconductor, Guardant…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
investors.com4
-
tradingview.com2
-
fxempire.com1
-
genomeweb.com1
-
insidermonkey.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.